| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
48,515,000 |
| Market
Cap: |
14.07(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.043 - $9.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 554 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile NanoString Technologies develops, manufactures and sells products that unlock scientifically and clinically actionable information from minute amounts of biological material. Co.'s technologies include proprietary chemistries that enable the labeling and counting of single molecules. Co.'s product platforms are used for scientific and clinical research applications. Co. provides two commercially available product platforms, its nCounter Analysis System, and its GeoMx Digital Spatial Profiler DSP, system. Co. has one additional product platform under development, its CosMx Spatial Molecular Imager system. All Co.'s product platforms include instruments, consumables, software and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
80,400 |
201,722 |
| Total Buy Value |
$0 |
$0 |
$461,956 |
$1,419,275 |
| Total People Bought |
0 |
0 |
3 |
5 |
| Total Buy Transactions |
0 |
0 |
3 |
8 |
| Total Shares Sold |
0 |
0 |
0 |
1,945 |
| Total Sell Value |
$0 |
$0 |
$0 |
$24,137 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-03-15 |
4 |
S |
$27.81 |
$67,740 |
D/D |
(2,436) |
85,372 |
|
59% |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-03-15 |
4 |
S |
$27.81 |
$239,844 |
D/D |
(8,625) |
202,298 |
|
59% |
|
| Bailey K Thomas |
Chief Financial Officer |
• – – |
2022-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,377 |
21,482 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,377 |
87,808 |
|
- |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,994 |
210,923 |
|
- |
|
| Bailey K Thomas |
Chief Financial Officer |
• – – |
2022-03-10 |
4 |
S |
$33.81 |
$169,050 |
D/D |
(5,000) |
16,105 |
|
64% |
|
| Bailey K Thomas |
Chief Financial Officer |
• – – |
2022-03-08 |
4 |
S |
$33.06 |
$101,110 |
D/D |
(3,058) |
21,105 |
|
65% |
|
| George Janet |
Director |
– • – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,676 |
1,676 |
|
- |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-03-08 |
4 |
S |
$33.06 |
$319,630 |
D/D |
(9,667) |
188,929 |
|
65% |
|
| Rollison Dana E. |
Director |
– • – |
2022-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,676 |
1,676 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-03-08 |
4 |
S |
$33.06 |
$98,134 |
D/D |
(2,968) |
82,431 |
|
65% |
|
| Bailey K Thomas |
Chief Financial Officer |
• – – |
2022-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,753 |
24,163 |
|
- |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,526 |
198,596 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,505 |
85,399 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-03-01 |
4 |
A |
$30.21 |
$10,936 |
D/D |
362 |
78,894 |
|
- |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-03-01 |
4 |
A |
$30.21 |
$12,899 |
D/D |
427 |
174,070 |
|
- |
|
| Young William |
Director |
– • – |
2022-02-24 |
4 |
AS |
$29.66 |
$655,029 |
D/D |
(20,343) |
7,410 |
|
-58% |
|
| Young William |
Director |
– • – |
2022-02-24 |
4 |
OE |
$1.92 |
$39,059 |
D/D |
20,343 |
27,753 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-01-27 |
4 |
D |
$31.00 |
$207,266 |
D/D |
(6,686) |
78,532 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,709 |
85,218 |
|
- |
|
| Bailey K Thomas |
Chief Financial Officer |
• – – |
2022-01-27 |
4 |
D |
$31.00 |
$109,058 |
D/D |
(3,518) |
16,410 |
|
- |
|
| Bailey K Thomas |
Chief Financial Officer |
• – – |
2022-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,709 |
19,928 |
|
- |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-01-27 |
4 |
D |
$31.00 |
$688,913 |
D/D |
(22,223) |
173,643 |
|
- |
|
| Gray R Bradley |
President and CEO |
• • – |
2022-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
56,085 |
195,866 |
|
- |
|
| Beechem Joseph M |
SVP, Research & Development |
• – – |
2022-01-26 |
4/A |
D |
$31.99 |
$93,635 |
D/D |
(2,927) |
71,509 |
|
- |
|
612 Records found
|
|
Page 3 of 25 |
|
|
0.01 (1.75%) 
